Clinical Trial Update: Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects Without Diabetes Mellitus [Phase 2]

View source ↗

Summary

This update reports the completed Phase 2 trial evaluating the safety and efficacy of CPX101 in overweight and obese adults without diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CPX101

Snippet

Sponsor: Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd. | Conditions: Overweight and Obesity | Phase 2 | Status: COMPLETED